Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Claridgeon Nov 07, 2019 4:18pm

94 Views

Post# 30323852

RE:USA

Jojomarch ... Thanks for re-posting that excerpt of a recent news release as everything is stated in it.

Some should re-read this carefully instead of looking for issues because they forgot about these projections that are still ahead of us, not behind us.

________________

jojomarch - (11/7/2019 3:42:25 PM)
USA

The Company anticipates that patient enrollment and treatment will escalate rapidly with the increased momentum as it launches additional clinical study sites, as UHN has now treated its second patient.

Shawn Shirazi, Ph.D., CEO - Drug Division, Theralase stated that, "I'm delighted that a high-quality organization such as LHSC has elected to join the Theralase team as the third Canadian study site that can enroll and treat patients with NMIBC, who are BCG-Unresponsive. We are working towards onboarding the rest of the Canadian study sites for Study II by the end of the year and hope to bring some US study sites on board before year end

By the end of the year\Before tear end

Sounds like we should expect many NRs before ringing in the New Year

____________________

Thursday, October 31, 2019